Rebecca Guzman focuses her practice on mergers and acquisitions, joint ventures, complex internal corporate restructuring transactions, and Delaware corporate and alternative entity law. Her recent representations include advising:

  • Alexander & Baldwin on its conversion to a REIT, including an internal realignment involving the serialization of its operating company and other subsidiaries;
  • Patheon N.V. in its $7.2 billion sale to Thermo Fisher Scientific, Inc.;
  • JLL Partners and Water Street Healthcare Partners in the acquisition by their portfolio company MedPlast of Vention Medical;
  • Hg in its acquisition of a majority interest in the Rhapsody business of Orion Health Group Limited;
  • DowDuPont in the separation of its specialty products businesses; and
  • various public and private clients in connection with complex internal corporate restructuring transactions.

Before law school, Ms. Guzman was a Fulbright Scholar in Jakarta, Indonesia.



  • J.D., University of California, Berkeley School of Law, 2013 (Prosser Prize in Negotiations)
  • B.A., Lehigh University, 2007 (Phi Beta Kappa; highest honors)


  • Delaware
  • New York

Rebecca A. Guzman

Associate, Mergers and Acquisitions